AZTA Azenta, Inc.
$40.63▲ +3.97%
Healthcare
Other
After hours
$40.83▲ +0.49%
Oct 28, 4:46 PM ET
Volume 900.7K
Avg Volume (10D) 941.6K
Key Metrics & Fundamentals
Market Cap
$1.78B
P/E Ratio
–
Div Yield
0.00%
52W Range
15.93 - 46.41
% vs 50 MA
16.74%
% vs 200 MA
43.28%
RSI-14
65.1
MACD Histogram
+0.1900
Beta (1Y vs SPY)
1.50
Free Cash Flow
-$3.87M
Gross Rev
$161.18M
Gross Profit
$72.36M
EBITDA
$10.43M
COGS
$88.82M
Operating Exp
$76.02M
Operating Income
-$3.67M
EBIT
-$3.67M
Pretax Income
$846,000
Net Income
$2.46M
EPS (Diluted)
0.05
Price & Volume History
Loading chart…
Recent News
Azenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast
PR Newswire · Oct 28, 2026 4:05 PM ET
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
StockStory · Oct 19, 2026 6:00 PM ET
Azenta (AZTA) Could Be 14% Below Fair Value Following Margin Expansion Narrative
Simply Wall St. · Oct 18, 2026 6:18 AM ET
Azenta (AZTA) Stock Could Be Undervalued Even With Legal Scrutiny
Simply Wall St. · Oct 18, 2026 3:12 AM ET
Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
StockStory · Oct 16, 2026 4:43 PM ET
2 Volatile Stocks with Promising Prospects and 1 We Ignore
StockStory · Oct 15, 2026 7:36 AM ET
Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)
StockStory · Sep 14, 2026 5:31 PM ET
Brooks Automation Files Confidentially for IPO
The Wall Street Journal · Sep 10, 2026 10:56 AM ET
Azenta Receives Early Repayment of $35 Million Vendor Loan
MT Newswires · Sep 4, 2026 8:53 AM ET
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
PR Newswire · Sep 4, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AZTA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.